Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 6.25
0.00 (0.00%)
At close: Jan 23, 2026
Renalytix Market Cap
Renalytix has a market cap or net worth of 27.31 million as of January 23, 2026. Its market cap has decreased by -31.28% in one year.
Market Cap
27.31M
Enterprise Value
30.67M
Revenue
2.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.25
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 27.31M, a decrease of -57.71%. That is a compound annual growth rate of -11.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 27.31M | 5.93% |
| Dec 31, 2025 | 25.78M | -27.58% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.30B |
| GSK plc | 72.40B |
| Haleon | 33.68B |
| Smith & Nephew | 10.50B |
| Arecor Therapeutics | 31.15M |
| Poolbeg Pharma | 29.98M |
| Sareum Holdings | 26.92M |
| Abingdon Health | 26.00M |